NCT02475720View on ClinicalTrials.gov

Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

June 19, 2015

Primary Completion Date

March 16, 2016

Study Completion Date

March 16, 2016

Conditions
Carcinoma, Non-Small-Cell Lung
Trial Locations (1)

594-0071

Izumi Municipal Hospital, Izumi

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY